Download the whitepaper to learn how to mitigate some of the most common and pressing challenges faced during the cell and gene therapy supply chain.

Integrated supply chain logistics in cell and gene therapy clinical trials

The Impact of Integrated Logistics for Cell and Gene Therapy Clinical Trials: maintaining cryogenic temperatures during storage & transport, delivering therapies within their visibility window, incorporating real-time visibility into tracking & monitoring, and anticipating & mitigating risks to the supply chain

Integrated supply chain logistics are uniquely challenging, and integral, to the success of a cell and gene therapy (CGT) clinical trial. Many cell
and gene therapies have short shelf lives, requiring cryogenic transport and prompt delivery to remain viable and potent. Meanwhile, CGT clinical trials place patients at the center of the supply chain, requiring seamless coordination between many stakeholders and the infrastructure to maintain chain of identity and chain of custody at all
times.

In this whitepaper, we review how an experienced logistics provider can help ensure that these very high-value products are shipped with care, and make it to the patient on time.

Fill out the form to download the whitepaper